Institutional Ownership
Recursion Pharmaceuticals In
CUSIP 75629V104CL ARXRXQ1 2026
Institutional Holders
327
13F filers
Shares Held
286.55M
Aggregate institutional
Institutional Value
$871.92M
Q1 2026
Net New Holders
+8
53 new · 45 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions53
Increased133
Decreased81
Sold out45
Institutional Holders
327 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 43.19M | $132.60M | +4.33M | Added |
| 2 | Ark Investment Management LLC | 40.21M | $123.45M | +2.90M | Added |
| 3 | State Street Corp | 28.49M | $87.47M | +3.16M | Added |
| 4 | Baillie Gifford & Co | 23.68M | $72.68M | −99.6K | Reduced |
| 5 | Softbank Group Corp. | 13.64M | $41.86M | 0 | Held |
| 6 | Geode Capital Management, LLC | 12.28M | $37.69M | +1.34M | Added |
| 7 | Mic Capital Management Uk LLP | 9.64M | $29.61M | 0 | Held |
| 8 | Goldman Sachs Group Inc | 6.07M | $18.62M | +3.86M | Added |
| 9 | Data Collective IV Gp, LLC | 5.94M | $18.24M | 0 | Held |
| 10 | Lingotto Investment Management LLP | 5.88M | $18.06M | +950.7K | Added |
317 more institutional holders on Premium
See every fund holding Recursion Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders